$104.91
+0 (+0%)
At Close: Jun 22, 2026
A Preview Of Exact Sciences's Earnings
10:34am, Monday, 15'th Feb 2021
Exact Sciences (NASDAQ:EXAS) announces its next round of earnings this Tuesday, February 16. Here is Benzinga's look at Exact Sciences's Q4 earnings report.
Is a Surprise Coming for Exact Sciences (EXAS) This Earnings Season?
09:53am, Friday, 12'th Feb 2021
Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
01:39pm, Tuesday, 09'th Feb 2021
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exact Sciences schedules fourth quarter 2020 earnings call
06:00am, Monday, 01'st Feb 2021
MADISON, Wis., Feb. 1, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close of the U.S.
Stock Indexes Hold Tough, But Leaders Struggle: Datadog, Exact Sciences, Freeport McMoRan In Focus
04:18pm, Tuesday, 26'th Jan 2021
Stock indexes hold tough, but leaders struggle: Datadog, Exact Sciences, Freeport McMoRan in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stoc
Exact Sciences: Patching The Acquisitions Together
08:57am, Thursday, 21'st Jan 2021
Exact Sciences: Patching The Acquisitions Together
MADISON, Wis., Jan. 12, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for Cancer Research
Exact Sciences (EXAS) Soars: Stock Adds 9.8% in Session
09:47am, Tuesday, 12'th Jan 2021
Exact Sciences (EXAS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Why Eli Lilly, Exact Sciences, Biogen Are Trading Higher Today
12:36pm, Monday, 11'th Jan 2021
Exact Sciences (NASDAQ: EXAS) shares are trading higher after the company issued fourth-quarter sales guidance above analyst estimates. Exact Sciences is a molecular diagnostics company focused on the
Why Exact Sciences Stock Is Soaring Today
11:01am, Monday, 11'th Jan 2021
Investors really liked the company's sneak peek at its fourth-quarter results.
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
07:30pm, Sunday, 10'th Jan 2021
MADISON, Wis., Jan. 10, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for the fourth qua
Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
08:25am, Tuesday, 05'th Jan 2021
MADISON, Wis., Jan. 5, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has completed its previously announced acquisition of Thrive Earlier Detection Corp. ("Thrive").
Exact Sciences to participate in J.P. Morgan Healthcare Conference
06:00am, Monday, 28'th Dec 2020
MADISON, Wis., Dec. 28, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participa
3 Stocks Growing Earnings Fast
10:04am, Tuesday, 22'nd Dec 2020
The S&P 500 saw its trailing 12-month real earnings per share (EPS) grow by approximately 1% on average every year over the past five years. The index's share price ($3,694.92 as of Monday) increased
Indexes Close Off Lows After Virus Scare; Nike, Generac, Exact Sciences In Focus
04:04pm, Monday, 21'st Dec 2020
The stock market turned in resilient performance Monday, overcoming early fears of a new coronavirus strain in the U.K. Investor's Business Daily has been helping people invest smarter results by prov
Sign In
Buy EXAS